Opportunities Preloader

Please Wait.....

Report

Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033

Market Report I 2025-02-10 I 140 Pages I IMARC Group

The Europe specialty generics market size reached USD 21.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.0 Billion by 2033, exhibiting a growth rate (CAGR) of 7.34% during 2025-2033. The increasing prevalence of chronic diseases, rising demand for affordable medicines, and implementation of favorable regulatory guidelines are some of the key factors driving the market.

Specialty generics refer to complex, difficult-to-produce medications that are created as a lower-cost alternative to brand-name drugs. These drugs are generally used to treat chronic conditions and diseases that require long-term therapy, such as cancer, autoimmune disorders, and human immunodeficiency virus (HIV). Specialty generics should be identical in both chemical structure and therapeutic effect to the brand-name drug it is intended to replace. The production of these drugs requires a high level of expertise and sophisticated technology to ensure quality control and consistency. Specialty generics are composed of the same active ingredient as the brand-name drug but may differ in other components, such as excipients, fillers, and binders. Currently, there are two types of product variants, such as biosimilars and complex generics. Biosimilars are drugs that are similar to biologic drugs, whereas complex generics are generic versions of drugs that are chemically and structurally complex.

Europe Specialty Generics Market Trends:

Europe specialty generics market is primarily boosted by the growing geriatric population, increasing prevalence of chronic diseases, and the rising demand for affordable medicines. Additionally, the implementation of favorable regulatory guidelines by the European Medicines Agency (EMA) and the increasing adoption of biosimilars are boosting the market growth. Apart from this, several manufacturers are developing cost-effective biosimilars that offer similar efficacy and safety as branded drugs, which is providing an impetus to the market growth. Furthermore, burgeoning investments by leading pharmaceutical companies in research and development (R&D) activities to develop innovative drugs and the rising awareness about the benefits of specialty generic drugs are providing a considerable thrust to the market growth. Moreover, the integration of robotics and artificial intelligence (AI) in the manufacturing process to enable automation, reduce manual labor, maintain product quality, and enhance overall efficiency is positively influencing the market growth. Besides this, the increasing focus on expanding the product portfolio by key players, the growing demand for personalized medicine, the surging adoption of e-prescriptions, the increasing consumer awareness and acceptance of specialty generics, rising healthcare expenditure, extensive research and development (R&D) activities, and the development of novel drug delivery technologies are accelerating the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2025-2033. Our report has categorized the market based on route of administration, indication and distribution channel.

Route of Administration Insights:

- Injectables
- Oral
- Others

The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the route of administration. This includes injectables, oral, and others. According to the report, the injectables segment dominates the market.

Indication Insights:

- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Others

The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the indication. This includes oncology, autoimmune diseases, infectious diseases, and others. According to the report, the oncology segment dominates the market.

Distributional Channel Insights:

- Retail Pharmacies
- Specialty Pharmacies
- Hospital Pharmacies

The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the distributional channel. This includes retail pharmacies, specialty pharmacies, and hospital pharmacies. According to the report, the retail pharmacies segment holds the largest market share.

Regional Insights:

- Italy
- Germany
- France
- United Kingdom
- Spain
- Rest of Europe

The report has also provided a comprehensive analysis of all the major regional markets, which include. Italy, Germany, France, the United Kingdom, Spain, and the Rest of Europe. As per the report, Italy dominates the market. Some of the factors accelerating the Italy specialty generics market include the surging awareness regarding the advantages of specialty generics, inflating consumer per capita income, and the growing prevalence of chronic diseases.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the Europe specialty generics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. The leading players in the European specialty generics industry have also been examined in the report.

Key Questions Answered in This Report

1.What was the size of the Europe specialty generics market in 2024?

2.What is the expected growth rate of the Europe specialty generics market during 2025-2033?

3.What are the key factors driving the Europe specialty generics market?

4.What has been the impact of COVID-19 on the Europe specialty generics market?

5.What is the breakup of the Europe specialty generics market based on the route of administration?

6.What is the breakup of the Europe specialty generics market based on the indication?

7.What is the breakup of the Europe specialty generics market based on the distribution channel?

8.What are the key regions in the Europe specialty generics market?

?1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Europe Specialty Generics Market: Introduction
5 Why are Specialty Generics So Lucrative?
6 Europe Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 Market Breakup by Route of Administration
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Indication
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 United Kingdom
10.3.1 Market Overview
10.3.2 Market Performance
10.4 Spain
10.4.1 Market Performance
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players


Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion USD), 2019-2024
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2024
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2024
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2024
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2024
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter's Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion USD), 2019 & 2024
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion USD), 2019 & 2024
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion USD), 2019 & 2024
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion USD), 2019 & 2024
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion USD), 2019 & 2024
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion USD), 2019 & 2024
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion USD), 2019 & 2024
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion USD), 2019 & 2024
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion USD), 2025-2033
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion USD), 2019 & 2024
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion USD), 2025-2033
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion USD), 2019 & 2024
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion USD), 2025-2033
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 34: France: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033

Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2024 and 2033
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion USD), 2025-2033
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion USD), 2025-2033
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion USD), 2025-2033
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion USD), 2025-2033
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $2999.00
  • $3999.00
  • $4999.00
  • ADD TO BASKET
  • BUY NOW